SCHEMBL8505690

SCHEMBL8505690

NS(=O)(=O)c1ccccc1-c1cccn1C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 1/20 0.37
CA1 P00915 5/20 0.37
CA2 P00918 5/20 0.37
CA12 O43570 4/20 0.37
CA9 Q16790 4/20 0.37
ALDH1A1 P00352 2/20 0.37
SCN9A Q15858 4/20 0.36
CYP2C9 P11712 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
TSHR P16473 1/20 0.35
PTGS2 P35354 1/20 0.34
CA4 P22748 2/20 0.34
CA6 P23280 2/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
F10 P00742 2/20 0.33
MEN1 O00255 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215974 0.76 PTGS2 (0.55) CA1CA2CA12CA9PTGS2
SCHEMBL8505098 0.76 PTGS2 (0.52) PTGES2CA1CA2CA12CA9
SCHEMBL8250269 0.71 SLC18A3 (0.43) CA1CA2CA12CA9ALDH1A1
SCHEMBL28244347 0.70 GAA (0.40) ALDH1A1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL8503387 0.69 PTGS2 (0.44) CA1CA2CA12CA9ALDH1A1
SCHEMBL8347239 0.69 CA2 (0.58) CA1CA2CA12CA9CYP2C9
SCHEMBL1080972 0.67 CA2 (0.61) CA1CA2CA12CA9CYP2C9
SCHEMBL11163075 0.65 SLC18A3 (0.34) ALDH1A1MEN1KMT2A
SCHEMBL28919430 0.65 ALDH1A1 (0.43) ALDH1A1TSHRKMT2ACYP1A2SMN1; SMN2
SCHEMBL8505826 0.65 PTGS2 (0.44) PTGES2CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935990-A PYRROLYL DERIVATIVES HAVING AT POSITION 1 OR 5 A PHENYL SUBSTITUTED WITH METHYLSULFONYL OR AMINOSULFONYL; INHIBIT CYCLOOXYGENASE-2 FOR USE TREATMENT OF INFLAMMATION, AS AN ANALGESIC, OR AS AN ANTIPYRETIC G.D. SEARLE & CO. (US) 1999-08-10 US disclosed